Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arezou Dabiri
Institution:
Isfahan University of Medical Sciences
Observed institution:
Isfahan University of Medical Sciences
ORCID:
0000-0002-0879-2511
Observed ORCID:
0000-0002-0879-2511
OpenAlex ID:
A5081554832
A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma
2023
·
Azadeh Rahimi
, Yasaman Esmaeili
, et al.
·
European Journal of Pharmaceutical Sciences
·
38
Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer
2024
·
Yasaman Esmaeili
, Arezou Dabiri
, et al.
·
Biomedicine & Pharmacotherapy
·
28
Smartphone-assisted lab-in-a-tube device using gold nanocluster-based aptasensor for detection of MUC1-overexpressed tumor cells
2023
·
Alireza Sanati
, Yasaman Esmaeili
, et al.
·
Analytica Chimica Acta
·
24
UiO-66 Metal-organic Framework (MOF) as an Osteogenic Stimulant in the Poly-3-hydroxybutyrate-zein/UiO-66 Electrospun Composite Scaffold for Bone Tissue Engineering Applications
2025
·
Saeid Ghasemi
, Mahdie Esmaeili
, et al.
·
Journal of Polymers and the Environment
·
21
Advances in bioengineered CAR T/ NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/ NK cell therapy
2024
·
Nasim Dana
, Arezou Dabiri
, et al.
·
Bioengineering & Translational Medicine
·
14
Author response for "Advances in bioengineered CAR T/ NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/ NK cell therapy"
2024
·
Nasim Dana
, Arezou Dabiri
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
6
Citation count:
125
H-index:
5
I10-index:
5
Year
Topic
Type